» Articles » PMID: 164893

Iodohexestrols. II. Characterization of the Binding and Estrogenic Activity of Iodinated Hexestrol Derivatives, in Vitro and in Vivo

Overview
Journal Biochemistry
Specialty Biochemistry
Date 1975 Apr 22
PMID 164893
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

The affinity of ortho-iodinated hexestrols for the estrogen binding protein from rat uterus, determined by competitive binding assay, decreases with progressive iodine substitution; 3-iodohexestrol (I-Hex) has a binding affinity 42% that of estradiol. Analysis of [3-H]-I-Hex binding in rat uterine cytosol by sucrose density gradient centrifugation shows both an estrogen-specific binding component (8 S) and a more abundant component (4 S) that is not estrogen specific. Scatchard analysis indicates that this latter binding is of high affinity (Kd equals to 3.7-8.3 times 10- minus-9 M) but is not uterine specific. Polyacrylamide gel electrophoresis shows that most of the [3-H]-I-Hex binding activity in serum and uterine cytosol is distinct from and anodic to the principal protein component (albumin), and that is comigrates with [14-C]thyroxine binding activity. In in vitro incubation of rat uteri, I-Hex can block the specific uptake of [3-H]estradiol into the nuclear fraction; it itself causes a translocation of estrogen-specific binding capacity (as measured by exchange) from cytoplasm to nuclei, and can induce the synthesis of an estrogen-specific uterine protein, all under conditions where it is not metabolically deiodinated to hexestrol. The uterotrophic activities of the iodohexestrols are in most cases comparable to that expected on the basis of their competitive binding affinities. However, selective, estrogen-specific uptake of [3-H]-I-Hex into rat uterus, either in vitro or in vivo, cannot be demonstrated.

Citing Articles

PET Imaging Agents (FES, FFNP, and FDHT) for Estrogen, Androgen, and Progesterone Receptors to Improve Management of Breast and Prostate Cancers by Functional Imaging.

Katzenellenbogen J Cancers (Basel). 2020; 12(8).

PMID: 32718075 PMC: 7465097. DOI: 10.3390/cancers12082020.


The quest for improving the management of breast cancer by functional imaging: The discovery and development of 16α-[F]fluoroestradiol (FES), a PET radiotracer for the estrogen receptor, a historical review.

Katzenellenbogen J Nucl Med Biol. 2020; 92:24-37.

PMID: 32229068 PMC: 7442693. DOI: 10.1016/j.nucmedbio.2020.02.007.


Targeted functional imaging in breast cancer.

Kumar R Eur J Nucl Med Mol Imaging. 2007; 34(3):346-53.

PMID: 17404770 DOI: 10.1007/s00259-006-0284-2.


Characterizing tumors using metabolic imaging: PET imaging of cellular proliferation and steroid receptors.

Mankoff D, Dehdashti F, Shields A Neoplasia. 2000; 2(1-2):71-88.

PMID: 10933070 PMC: 1531868. DOI: 10.1038/sj.neo.7900075.


The uptake of radioiodinated 5 alpha-dihydrotestosterone by the prostate of intact and castrated rats.

Tarle M, Padovan R, Spaventi S Eur J Nucl Med. 1981; 6(2):79-83.

PMID: 7202428 DOI: 10.1007/BF00253718.